Clinical Trial Update: Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating dipyridamole to prevent post-transplant hypophosphatemia in kidney transplant recipients. The tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypophosphatemia
• Kidney Transplantation

Drugs mentioned

• Dipyridamole (Dipyridamole)

Snippet

Sponsor: Stanford University | Conditions: Hypophosphatemia, Kidney Transplantation | Phase 2 | Status: NOT_YET_RECRUITING